Skip to content

Episode 10: What Pharma Leaders Are Actually Talking About in 2026

Suzy Wang, Research and Production Lead at Reuters Events, reveals the biggest shift in pharma industry conversations this year; AI isn't just a strategy anymore, it's about scaling real impact and ROI.

Listen to the podcast with Suzy on YouTube here

Episode 9: Making digital transformation feel human again in pharma, with Dan Atkins, Shionogi Europe

This conversation explores what it really takes to turn digital tools into a genuinely better experience for physicians and patients alike, with Dan Atkins, Head of Customer Excellence and Digital at Shionogi Europe.

Listen to the podcast with Dan on YouTube here

Episode 8: Why climate change is a health issue, not just an environmental one

Dr. Emma Iavoli, Lead for Medical Sustainability at Bayer, argues climate change isn't a side project. It's a public health crisis, already affecting patients today.

Listen to the interview with Emma Lavoli here

Episode 7: Why patient engagement needs a system, not just champions

Mark Duman, founder of patient advocacy organization Illuminate, argues that patient engagement in pharma is still too often down to individual champions, not standard practice.

Listen to the interview with Mark Duman on YouTube here

Episode 6: Solving the single-country dependency problem in plasma medicine

Roland Wandeler, President of Biopharma at Grifols, explains why plasma-derived medicines depend entirely on voluntary donations, not manufacturing capacity. Right now, roughly two-thirds of global supply comes from a single country.

Listen to the interview with Roland Wandeler on YouTube here

Episode 5: Why food might be the pharma industry's next big medicine

Luis Briz, President of Professional Health at Nestlé Health Science, explores the unusual space where pharma, nutrition and consumer health collide, and what it means for the future of patient care.

Listen to the interview with Luis Britz on YouTube here

Episode 4: Why oncology launches need a clinician's lens, not a commercial one

Dicla Veliz Salce, Breast Cancer Executive Director at AstraZeneca, draws on her training as a physician to explain why real understanding of unmet need starts in the clinic.

Listen to the conversation with Dicla Veliz Salce on YouTube here

Episode 3: Pharma launches are behaviour change at scale

Tom Lampron shares why successful launches depend on early momentum, rigorous planning and the courage to adapt fast.

Listen to the conversation with Tom Lampton on YouTube here

Episode 2: Why direct-to-patient access is ready for prime time

This conversation with Dr. Paul Burton, Chief Medical Officer at Amgen, covers why direct-to-patient models are becoming a bigger part of the future of pharma access.

Listen to the interview with Paul Burton on YouTube here.

Episode 1: Embedding health equity into pharma launches from day one

Erica Smith, Vice President of Value and Market Access at Chiesi Pharmaceuticals, explores what it really takes to build health equity into pharma launch strategy from the start.

Listen to the interview with Erica Smith on YouTube here